MICROVASCULAR THERAPEUTICS INC — Federal Contracts, Awards & Government Contractor Profile

About MICROVASCULAR THERAPEUTICS INC

MVT Pharma is a biotechnology company pioneering ultrasound contrast agents and theranostics, with several patented formulations in various stages of clinical development, including MVT-100, which has completed Phase II trials. The company focuses on transforming ultrasound from imaging to therapeutic applications.

Development of ultrasound contrast agentsTheranostics research and developmentMolecular imaging and image-guided therapy platform developmentNon-thermal brain tumor ablation using nanobubbles and MRgFUSSonothrombolysis for conditions like stroke and myocardial microvascular obstructionAmyloid plaque dissolution for Alzheimer's diseasePancreatic cancer detectionBreast cancer detection and differentiation

Is this your company?

Claim MICROVASCULAR THERAPEUTICS INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.

Claim MICROVASCULAR THERAPEUTICS INC & see your matches

Free to claim. Takes about a minute.

Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.